Craven House Capital PLC Share Price London S.E.
Equities
GB00B01TVW49
Investment Management & Fund Operators
End-of-day quote
Other stock markets
|
||
- GBX | - |
28/02 | EARNINGS: Hutchmed revenue surges, Craven House's loss widens | AN |
28/02 | Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 7L 5.48Cr |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -50L -42Cr | EV / Sales 2022 | - |
Net cash position 2022 | 1T 83.51T | Net cash position 2023 | 4T 3L | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.93
x | P/E ratio 2023 |
-0.12
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.73% |
Managers | Title | Age | Since |
---|---|---|---|
Tamra Spink
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pajak
CHM | Chairman | 45 | 31/10/31 |
Balbir Bindra
BRD | Director/Board Member | - | 27/11/27 |
Calum Morrison
BRD | Director/Board Member | 55 | 05/16/05 |
1st Jan change | Capi. | |
---|---|---|
-6.67% | 11TCr | |
+6.74% | 9.91TCr | |
+6.47% | 6.37TCr | |
+12.89% | 4.39TCr | |
+11.11% | 4.19TCr | |
+24.58% | 3.64TCr | |
+6.31% | 2.56TCr | |
-8.17% | 2.14TCr | |
-1.25% | 1.82TCr |